From a higher bar for regulatory clearance to pricing limitations, drug development is more expensive than ever. This has led ...

Life sciences employers have been impacted by various market forces in the last several years, and the recent economic ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...